ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

IBT International Biotechnology Trust Plc

708.00
8.00 (1.14%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust Plc LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  8.00 1.14% 708.00 714.00 716.00 720.00 706.00 706.00 132,379 16:35:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Trust,ex Ed,religious,charty 12.06M 6.81M 0.1835 38.91 259.91M

Intl. Biotechnology Trust PLC Latest Factsheet and Blog

06/06/2024 12:38pm

RNS Non-Regulatory


RNS Number : 4536R
Intl. Biotechnology Trust PLC
06 June 2024
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

 

IBT's factsheet for the month ended 30 April 2024 is now available directly via its web page. Please click here, then 'latest factsheet'.

 

IBT recently celebrated its 30-year anniversary, having launched as a pioneering investment trust dedicated to the nascent opportunity in biotech back in 1994. In the latest blog post, Marking IBT's 30-year anniversary with a look at the transformation of cancer therapy, Fund Managers Ailsa Craig and Marek Poszepczynski explore the key developments in cancer treatment during this time and the outlook for future breakthroughs, which are collectively profoundly changing the prospects for many patients.

 

The blog can be read here: https://www.schroders.com/en-gb/uk/individual/content/marking-ibt-s-30-year-anniversary-with-a-look-at-the-transformation-of-cancer-therapy/

 

To sign up for IBT updates by email, please click here.

 

 

ENDS

 

 

Enquiries:

 

Schroder Investment Management Limited

 

Augustine Chipungu (Press)

Kirsty Preston

 

Kerry Higgins (Company Secretary)                   

 

 

020 7658 6000

 

 

020 7658 6000

 


 

Kaso Legg Communications (Financial PR)

 

Charles Gorman                       

Henry Taylor

Effie Aye Maung Hider

 

 

 

 

IBT@kl-communications.com


 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFQLFBZQLXBBD

1 Year International Biotechnol... Chart

1 Year International Biotechnol... Chart

1 Month International Biotechnol... Chart

1 Month International Biotechnol... Chart

Your Recent History

Delayed Upgrade Clock